Moderna Inc. Stock Slips 23.5%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.

Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.

Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 20, 2026 16:33 ET (20:33 GMT)